Stock Events

Stock Events

Amyris 

$0.05
158
-$0.01-21.87% Friday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
16.51M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

6NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.46
-0.21
0.05
0.3
Expected EPS
-0.2675
Actual EPS
N/A

Financials

-196.24%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
345.65MRevenue
-678.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMRS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Evogene
EVGN
Mkt Cap11.24M
Evogene operates in the biotechnology sector focusing on the development of products for various industries including chemicals and agriculture, overlapping with Amyris' market.
Codexis
CDXS
Mkt Cap213.93M
Codexis specializes in protein engineering and enzyme innovation, competing with Amyris in the market for sustainable chemical processes.
Gevo
GEVO
Mkt Cap565.9M
Gevo is involved in the renewable chemicals and advanced biofuels market, making it a competitor in Amyris' renewable product space.
Gracell Biotechnologies
GRCL
Mkt Cap989.87M
Grisel Industries competes in the biotech space, focusing on sustainable and environmentally friendly products, similar to Amyris' goals.
Synlogic
SYBX
Mkt Cap19.77M
Synlogic operates in the synthetic biology field, developing therapeutic drugs and competing with Amyris in the biotech innovation space.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap0
DSM is a global science-based company active in health, nutrition, and materials, competing with Amyris in the production of sustainable and bio-based products.
Archer Daniels Midland
ADM
Mkt Cap29.08B
Archer Daniels Midland Company is a global leader in bioenergy and naturally derived products, competing with Amyris in the broader market for sustainable biochemicals and biofuels.

About

Process Industries
Chemicals: Specialty
Manufacturing
Petroleum Refineries
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
Show more...
CEO
John Melo
Employees
980
Country
US
ISIN
US03236M2008
WKN
000A2DS41

Listings

0 Comments

Share your thoughts

FAQ

What is Amyris stock price today?▼
The current price of AMRS is $0.05 USD — it has decreased by -21.87% in the past 24 hours. Watch Amyris stock price performance more closely on the chart.
What is Amyris stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Amyris stocks are traded under the ticker AMRS.
What is Amyris market cap?▼
Today Amyris has the market capitalization of 16.51M
What is Amyris revenue for the last year?▼
Amyris revenue for the last year amounts to 345.65M USD.
What is Amyris net income for the last year?▼
AMRS net income for the last year is -678.31M USD.
How many employees does Amyris have?▼
As of April 04, 2026, the company has 980 employees.
In which sector is Amyris located?▼
Amyris operates in the Manufacturing sector.
When did Amyris complete a stock split?▼
The last stock split for Amyris was on June 06, 2017 with a ratio of 1:15.
Where is Amyris headquartered?▼
Amyris is headquartered in Emeryville, US.